Bladder cancer; Intravesical chemotherapy; Mitomycin C
Indexed keywords
MITOMYCIN C;
ARTICLE;
BLADDER CANCER;
CANCER PATIENT;
CANCER SURGERY;
DRUG SAFETY;
HUMAN;
MAJOR CLINICAL STUDY;
MEDICAL STAFF;
PAIN;
PRIORITY JOURNAL;
SUPERFICIAL CANCER;
TRANSURETHRAL RESECTION;
The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: A further report with 7 years of follow-up
Tolley DA Parmar MK Grigor KM et al. The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow-up J Urol 1996 155 1233 8
A prospective European Organisation for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder
Oosterlinck W Kurth KH Schroder FH Bultinck J Hammond B Sylvester R A prospective European Organisation for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder J Urol 1993 149 749 52
Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: Results of two European Organization for Research and Treatment of Cancer Genitourinary Group randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. European Organization for Research and Treatment of Cancer Genitourinary Group
Bouffioux C Kurth KH Bono A et al. Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of two European Organization for Research and Treatment of Cancer Genitourinary Group randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. European Organization for Research and Treatment of Cancer Genitourinary Group J Urol 1995 153 934 41
Perioperative single dose instillation of epirubicin or interferon-alpha after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: A prospective randomized multicenter study- Finnbladder III long-term results
Rajala P Kaasinen E Raitanen M Liukkonen T Rintala E the Finnbladder Group Perioperative single dose instillation of epirubicin or interferon-alpha after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: a prospective randomized multicenter study- Finnbladder III long-term results J Urol 2002 168 981 5
A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: A meta-analysis of published results of randomized clinical trials
Sylvester RJ Oosterlinck W van der Meijden AP A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials J Urol 2004 171 2186 90
Re: A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: A meta-analysis of published results of randomized clinical trials
Stewart AB Mostafid H Re: A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials J Urol 2005 173 1433
Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: Short and long term follow-up
Solsona E Iborra I Ricos JV Monros JL Casanova J Dumont R Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long term follow-up J Urol 1999 161 1120 3